Genetic modification of cancer cells using non-viral, episomal S/MAR vectors for in vivo tumour modelling.
about
Progresses towards safe and efficient gene therapy vectorsDevelopment and validation of non-integrative, self-limited, and replicating minicircles for safe reporter gene imaging of cell-based therapiesGenetic modification of dividing cells using episomally maintained S/MAR DNA vectors.Delivery of siRNA using ternary complexes containing branched cationic peptides: the role of peptide sequence, branching and targeting.Genome-wide profiling of S/MAR-based replicon contact sites.The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes
P2860
Genetic modification of cancer cells using non-viral, episomal S/MAR vectors for in vivo tumour modelling.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Genetic modification of cancer ...... for in vivo tumour modelling.
@ast
Genetic modification of cancer ...... for in vivo tumour modelling.
@en
Genetic modification of cancer ...... for in vivo tumour modelling.
@nl
type
label
Genetic modification of cancer ...... for in vivo tumour modelling.
@ast
Genetic modification of cancer ...... for in vivo tumour modelling.
@en
Genetic modification of cancer ...... for in vivo tumour modelling.
@nl
prefLabel
Genetic modification of cancer ...... for in vivo tumour modelling.
@ast
Genetic modification of cancer ...... for in vivo tumour modelling.
@en
Genetic modification of cancer ...... for in vivo tumour modelling.
@nl
P2093
P2860
P1433
P1476
Genetic modification of cancer ...... for in vivo tumour modelling.
@en
P2093
Kate Gowers
Orestis Argyros
Richard Paul Harbottle
Suet Ping Wong
P2860
P304
P356
10.1371/JOURNAL.PONE.0047920
P407
P577
2012-10-26T00:00:00Z